Decoy Therapeutics Inc.
DCOY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001615219
No open-market purchases or sales by Decoy Therapeutics Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $31.0K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Decoy Therapeutics Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- 0 vs. Q1 2021
- Shares held
- 10.1M
- −5.37M (−34.7%) vs. Q1 2021
- Total value
- $10.7M
- −$12.1M (−53.2%) vs. Q1 2021
- New holders
- 7
- 9 more added
- Sold out
- 7
- 10 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DCOY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $31.0K |
| Q1 2026 | 4 | $10.5K |
| Q4 2025 | 9 | $51.4K |
| Q3 2025 | 5 | $1.98K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 13 | $101.9K |
| Q4 2023 | 16 | $169.8K |
| Q3 2023 | 14 | $226.8K |
| Q2 2023 | 14 | $321.5K |
| Q1 2023 | 11 | $186.0K |
| Q4 2022 | 9 | $110.9K |
| Q3 2022 | 22 | $671.0K |
| Q2 2022 | 27 | $859.0K |
| Q1 2022 | 28 | $1.45M |
| Q4 2021 | 28 | $2.63M |
| Q3 2021 | 27 | $6.84M |
| Q2 2021 | 34 | $10.7M |
| Q1 2021 | 34 | $22.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Decoy Therapeutics Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 1,800,000 | $1.91M | 0.52% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,544,724 | $1.64M | 0.00% | +124,192+8.7% | Added |
| Sio Capital Management, LLC | 1,354,291 | $1.44M | 0.39% | −1,764,405−56.6% | Reduced |
| Maven Securities LTD | 1,316,205 | $1.37M | 0.14% | −609,830−31.7% | Reduced |
| Granite Point Capital Management, L.P. | 585,409 | $621.0K | 0.18% | −978,152−62.6% | Reduced |
| Kepos Capital LP | 548,054 | $581.0K | 0.04% | 00.0% | Unchanged |
| Morgan Stanley | 490,802 | $521.0K | 0.00% | +489,204+30,613.5% | Added |
| Silverarc Capital Management, LLC | 471,885 | $500.0K | 0.26% | −1,520,296−76.3% | Reduced |
| Worth Venture Partners, LLC | 424,800 | $450.0K | 0.17% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 277,035 | $293.0K | 0.00% | +153,574+124.4% | Added |
| Sabby Management, LLC | 249,033 | $264.0K | 0.06% | −17,922−6.7% | Reduced |
| Marshall Wace, LLP | 174,474 | $185.0K | 0.00% | +39,832+29.6% | Added |
| State Street Corp | 142,552 | $151.0K | 0.00% | +142,552 | New |
| BlackRock Inc. | 134,753 | $142.0K | 0.00% | +133,556+11,157.6% | Added |
| X-Square Capital, LLC | 100,458 | $106.0K | 0.05% | −65,250−39.4% | Reduced |
| Citadel Advisors LLC | 85,436 | $91.0K | 0.00% | +71,260+502.7% | Added |
| Northern Trust Corp | 65,022 | $69.0K | 0.00% | +13,374+25.9% | Added |
| Meitav Dash Investments Ltd | 52,000 | $55.0K | 0.00% | 00.0% | Unchanged |
| Wetherby Asset Management Inc | 39,746 | $42.0K | 0.00% | 00.0% | Unchanged |
| Monticello Wealth Management, LLC | 40,000 | $42.0K | 0.00% | +40,000 | New |
| Dimensional Fund Advisors LP | 36,634 | $39.0K | 0.00% | −25,205−40.8% | Reduced |
| Bank of New York Mellon Corp | 35,506 | $38.0K | 0.00% | −6,473−15.4% | Reduced |
| Millennium Management LLC | 33,488 | $35.0K | 0.00% | +4,813+16.8% | Added |
| Two Sigma Securities, LLC | 29,683 | $31.0K | 0.01% | +29,683 | New |
| Advisor Group Holdings, Inc. | 22,704 | $24.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 21,741 | $23.0K | 0.00% | +21,741 | New |
| Jane Street Group, LLC | 20,412 | $22.0K | 0.00% | +20,412 | New |
| Financial Advocates Investment Management | 11,472 | $12.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,500 | $7.00K | 0.00% | −6,079−48.3% | Reduced |
| Tower Research Capital LLC (TRC) | 135 | $0 | 0.00% | −58,685−99.8% | Reduced |
| Wells Fargo & Company | 262 | $0 | 0.00% | +107+69.0% | Added |
| Investors Research Corp | 11 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18 | $0 | 0.00% | +18 | New |
| FMR LLC | 1 | $0 | 0.00% | +1 | New |
| Altium Capital Management LP | 0 | $0 | 0.00% | −1,250,110−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −237,601−100.0% | Sold out |
| Douglass Winthrop Advisors, LLC | 0 | $0 | 0.00% | −78,806−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,479−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −10,708−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −6,942−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −200−100.0% | Sold out |